Abstract
Hepatitis C is a virus affecting millions worldwide and is a major health risk. With the potentially severe adverse event profile of the current backbone of therapy, interferon, there is an impetus to discover interferon free treatment regimens. With the development of new oral direct acting antivirals, interferon free regimens may be available in the next few years. This article discusses some of the preliminary data from interferon free studies.
Original language | English (US) |
---|---|
Pages (from-to) | 74-77 |
Number of pages | 4 |
Journal | Current Gastroenterology Reports |
Volume | 14 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2012 |
Externally published | Yes |
Keywords
- Direct acting antivirals
- Hepatitis C
- Interferon
- Interferon free
- Polymerase inhibitor
- Protease inhibitor
- Ribavirin
- SVR
ASJC Scopus subject areas
- Gastroenterology